Jiandong Wang

Beijing, CN 
Beijing, CN 

Overview

Jiandong Wang practices practicing medicine in Beijing, China.

Their clinical expertise encompasses Poland Syndrome, Breast Cancer, Syndactyly, Hepato-Pancreato-Biliary Surgery, and Mastectomy.

They are actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 2 clinical trials.

Locations

Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy
Enrollment Status: Unknown
Publish Date: November 29, 2021
Intervention Type: Drug
Study Drugs: AI adjuvant therapy, Chemotherapy
Study Phase: Phase 2
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
A Prospective, Randomized, Open, Multi-center Phase III Clinical Study Comparing Efficacy and Safety of Sequential T-FEC and TX-XEC as Post-operative Adjuvant Chemotherapy Options for the Treatment of Triple-negative Breast Cancer
Enrollment Status: Unknown
Publish Date: April 19, 2017
Intervention Type: Drug
Study Drugs: 5-Fu/Epirubicin/CTX Following Docetaxel, Docetaxel/Capecitabine Followed by Capecitabine/Epirubicin/Cyclophosphamide
Study Phase: Phase 3
View 1 Less Clinical Trial

17 Total Publications

Machine learning-based fusion model for predicting HER2 expression in breast cancer by Sonazoid-enhanced ultrasound: a multicenter study.
Machine learning-based fusion model for predicting HER2 expression in breast cancer by Sonazoid-enhanced ultrasound: a multicenter study.
Journal: Frontiers in medicine
Published: March 01, 2025

Frequently Asked Questions about Jiandong Wang

Is Jiandong Wang a top-rated expert for Poland Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Jiandong Wang is classified as an Experienced expert for Poland Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jiandong Wang participate in research or clinical trials?

Yes. Jiandong Wang has published 17 articles and abstracts on conditions like Poland Syndrome. You can view a list of Jiandong Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile